SDS

beta-Cyfluthrin wa
s not carcinogenic in lifetime feeding studies in rats and mice.
Imidacloprid was not carcinogenic in lifetime feeding studies in rats and mice.
ACGIH
None.
NTP
None.
IARC
None.
OSHA
None.
Assessment toxicity to reproduction
beta-Cyfluthrin caused reproduction toxicity in a two-generation stu
d
y in rats only at dose levels also
toxic to the parent animals. The reproduction toxicity seen with beta-Cyfluthrin is related to parental
toxicity.
Imidacloprid caused reproduction toxicity in a two-generation study in rats only at dose levels also toxic
to the parent animals. The reproduction toxicity seen with Imidacloprid is related to parental toxicity.
Assessment developmental toxicity
beta-Cyfluthrin caused developmental toxicity only at
dose levels to
xic to the dams. The developmental
effects seen with beta-Cyfluthrin are related to maternal toxicity.
Imidacloprid caused developmental toxicity only at dose levels toxic to the dams. The developmental
effects seen with Imidacloprid are related to maternal toxicity.
Further information
Acute toxicity studies have been bridge
d
from a similar formulation(s).
The non-acute information pertains to the active ingredient(s).
SECTION 12: ECOLOGICAL INFORMATION
Toxicity to fish
LC50 (Rainbow trout (Oncorhynchus mykiss)) 0.000068 mg/l
Exposure time: 96 h
The value mentioned relates to the active ingredient beta-cyfluthrin.
LC5
0
(Rainbow trout (Oncorhynchus mykiss)) 211 mg/l
Exposure time: 96 h
The value mentioned relates to the active ingredient imidacloprid.
Toxicity to aquatic
in
v
ertebrates
EC50 (Water flea (Daphnia magna)) 0.00029 mg/l
Exposure time: 48 h
The value mentioned relates to the active ingredient beta-cyfluthrin.
EC50 (Water
flea (Daphnia magna)) 85 mg/l
Exposure time: 48 h
The value mentioned relates to the active ingredient imidacloprid.
SBM LIFE SCIENCE CORP.
SA
FETY DATA SHEET
BIOADVANCED SCIENCE-BASED
SOLUTIONS COMPLETE BRAND ANT KILLER
PLUS(ALSO FOR FLEAS AND TICKS)
READY-TO-SPREAD GRANULES
Version 1.0 / USA
102000011911
7/10
Revision Date: 05/01/2017